Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Total Liabilities: 2020-2024

Historic Total Liabilities for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $354.5 million.

  • Cellebrite DI's Total Liabilities rose 16.83% to $386.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 24.94%. This contributed to the annual value of $354.5 million for FY2024, which is 28.90% down from last year.
  • As of FY2024, Cellebrite DI's Total Liabilities stood at $354.5 million, which was down 28.90% from $498.7 million recorded in FY2023.
  • Cellebrite DI's Total Liabilities' 5-year high stood at $498.7 million during FY2023, with a 5-year trough of $199.4 million in FY2020.
  • For the 3-year period, Cellebrite DI's Total Liabilities averaged around $394.2 million, with its median value being $354.5 million (2024).
  • In the last 5 years, Cellebrite DI's Total Liabilities skyrocketed by 107.21% in 2021 and then declined by 28.90% in 2024.
  • Cellebrite DI's Total Liabilities (Yearly) stood at $199.4 million in 2020, then skyrocketed by 107.21% to $413.1 million in 2021, then declined by 20.26% to $329.4 million in 2022, then skyrocketed by 51.38% to $498.7 million in 2023, then decreased by 28.90% to $354.5 million in 2024.